The ESMO Congress is the annual meeting of the European Society for Medical Oncology (ESMO), serving as a major global platform for oncology professionals including clinicians, researchers, patient advocates, and industry representatives.
The 2025 edition took place from October 17 to 21 at Messe Berlin in Berlin, Germany. It featured presentations of research across various cancer types, including data on treatments like pembrolizumab (KEYTRUDA), antibody-drug conjugates, and other investigational medicines. Highlights included sessions in Presidential Symposia on bladder, ovarian, and lung cancers.
